Munich - Delayed Quote EUR
Brii Biosciences Ltd (7SS.MU)
0.2220
+0.0060
+(2.78%)
At close: May 2 at 8:04:21 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-372,890
-372,890
-594,014
-496,279
-879,457
Investing Cash Flow
895,470
895,470
-104,350
-1,433,168
-475,756
Financing Cash Flow
-9,406
-9,406
-10,977
-3,042
3,230,134
End Cash Position
1,003,365
1,003,365
489,650
1,190,572
2,855,093
Capital Expenditure
-3,228
-3,228
-49,608
-139,292
-1,029
Issuance of Capital Stock
53
53
179
7,447
3,327,684
Repurchase of Capital Stock
-220
-220
-1,162
-678
--
Free Cash Flow
-376,118
-376,118
-643,622
-635,571
-880,486
12/31/2021 - 7/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
473A.SG Adaptimmune Therapeutics PLC
0.2440
+1.67%
41X.MU Ardelyx Inc
3.6740
-23.41%
IMR.F AC Immune SA
1.3940
-1.27%
MDG1.DE Medigene AG
0.1335
-27.64%
OCS Oculis Holding AG
18.87
+6.43%
ACET Adicet Bio, Inc.
0.6700
+6.60%
NKTX Nkarta, Inc.
2.0900
+1.95%
ADAP Adaptimmune Therapeutics plc
0.2859
+3.93%